Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Allergan Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011 Dec 31, 2010 Sep 30, 2010 Jun 30, 2010 Mar 31, 2010
Notes payable
Convertible notes
Accounts payable
Accrued compensation
Accrued legal settlement expenses
Other accrued expenses
Income taxes
Liabilities of discontinued operations
Current liabilities
Long-term debt, excluding current maturities
Long-term convertible notes
Other liabilities
Non-current liabilities
Total liabilities
Preferred stock, $.01 par value; none issued
Common stock, $.01 par value
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Treasury stock, at cost
Total Allergan, Inc. stockholders’ equity
Noncontrolling interest
Total equity
Total liabilities and equity

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).


Liabilities Overview
The total liabilities as a percentage of total liabilities and equity fluctuate between approximately 34% and 47%, indicating some volatility over the observed periods. Notably, there is a peak in liabilities in late 2010 and early 2013, followed by a moderate decline towards late 2014.
Current Liabilities
Current liabilities show irregular movements, with a significant peak at 24.51% in September 2010 and lower levels around 11-13% in the subsequent years. The data implies episodes of increased short-term obligations in early periods, with relatively stabilized but slightly increasing levels near the end of the timeline.
Long-Term Debt
Long-term debt, excluding current maturities, remains a substantial component, ranging roughly from 11.4% in early 2010 to a high of nearly 23% around the first quarter of 2013, then trending downward to approximately 16.8% by the end of 2014. This indicates debt restructuring or repayments during later periods.
Convertible Notes
Convertible notes are recorded primarily in mid to late 2010 and early 2011, comprising around 7-8% of total liabilities and equity, after which their presence declines to zero, suggesting the conversion or retirement of these instruments.
Accrued and Other Liabilities
Other accrued expenses exhibit a gradual increase from just above 5% to a peak exceeding 8% by late 2014, implying rising short-term obligations or accruals. Accrued compensation fluctuates between 1.3% and 2.6%, showing moderate variation likely linked to payroll and employee-related liabilities. 'Other liabilities' grow from around 5% to above 8% near the end of the period, indicating an increasing share of miscellaneous obligations.
Equity Composition
Total equity consistently accounts for about 57% to 65% of total liabilities and equity, with a dip in 2010-2011 and a gradual recovery from 2012 onwards. Additional paid-in capital declines steadily from nearly 36% in early 2010 to about 27% by the end of 2014, suggestive of reduced capital contributions or accounting adjustments.
Retained Earnings and Treasury Stock
Retained earnings display an overall upward trend, increasing steadily from approximately 33% to close to 47%, indicating accumulated profits over time. Conversely, treasury stock at cost shows a sizeable increase in negative value, particularly from 2012 onward, reaching as low as -12% near 2013 and around -8.8% in late 2014. This suggests substantial stock repurchases or retirements.
Comprehensive Loss and Other Equity Items
Accumulated other comprehensive loss remains negative throughout the periods, with increasing magnitude toward the end, reaching about -3.3%. This points to unfavorable adjustments in items such as foreign currency translation or pension liabilities. Common stock remains negligible and stable, while noncontrolling interest maintains a minimal portion around 0.07% to 0.31%.
Summary of Trends
The company’s financial structure reveals a shift from higher reliance on current liabilities and convertible notes in 2010-2011 towards a somewhat greater emphasis on long-term debt in subsequent years, albeit with gradual deleveraging from 2013 to 2014. Stockholders’ equity strengthens over time, supported primarily by rising retained earnings, despite decreasing additional paid-in capital and increasing treasury stock activity. The upward trajectory in accrued and other liabilities highlights a growing portion of operational or contingent obligations. Overall, the balance between liabilities and equity appears relatively stable with moderate fluctuations in specific categories reflecting changing financing and operational dynamics.